NR 508 Week 4 Midterm (Version 3)
Question 1: A patient who has primary hyperlipidemia and who takes atorvastatin (Lipitor) continues to have LDL cholesterol of 140 mg/dL after 3 months of therapy. The primary care NP increases the dose from 10 mg daily to 20 mg daily. The patient reports headache and dizziness a few weeks after the dose increase. The NP should:
a. recommend supplements of omega-3 along with the atorvastatin.
b. change the atorvastatin dose to 15 mg twice daily.
c. add ezetimibe (Zetia) and lower the atorvastatin to 10 mg daily.
d. change the patient’s medication to cholestyramine
Question 2: A patient who has hyperlipidemia has been taking atorvastatin (Lipitor) 60 mg daily for 6 months. The patient’s initial lipid profile showed LDL of 180 mg/dL, HDL of 45 mg/dL, and triglycerides of 160 mg/dL. The primary care NP orders a lipid profile today that shows LDL of 105 mg/dL, HDL of 50 mg/dL, and triglycerides of 120 mg/dL. The patient reports muscle pain and weakness. The NP should:
a.order liver function tests (LFTs).
b. order a creatine kinase-MM (CK-MM) level.
c. change atorvastatin to twice-daily dosing.
d. add gemfibrozil (Lopid) to the patient’s medication regimen
Question 3: A patient comes to the clinic with a 4-day history of 10 to 12 liquid stools each day. The patient reports seeing blood and mucus in the stools. The patient has had nausea but no vomiting. The primary care NP notes a temperature of 37.9° C, a heart rate of 96 beats per minute, and a blood pressure of 90/60 mm Hg. A physical examination reveals dry oral mucous membranes and capillary refill of 4 seconds. The NP’s priority should be to:
a. obtain stool cultures.
b. begin rehydration therapy.
c. consider prescribing metronidazole.
d. administer opioid antidiarrheal medications.
Question 4: A perimenopausal woman tells the primary care NP that she is having hot flashes and increasingly severe mood swings. The woman has had a hysterectomy. The NP should prescribe:
d. selective serotonin reuptake inhibitor therapy until menopause begins.
Question 5: A primary care NP prescribes a nitroglycerin transdermal patch, 0.4 mg/hour release, for a patient with chronic stable angina. The NP should teach the patient to:
d. apply one patch daily in the morning and remove in 12 hours.
Question 6: A parent calls a clinic for advice about giving an over-the-counter cough medicine to a 6-year-old child. The parent tells the NP that the medication label does not give instructions about how much to give a child. The NP should:
d. tell the parent to approximate the dose at about one third to one half the adult dose.
Question 7: A patient who has disabling intermittent claudication is not a candidate for surgery. Which of the following medications should the primary care NP prescribe to treat this patient?
d. Low-dose, short-term aspirin
Question 8: The primary care NP prescribes an extended-cycle monophasic pill regimen for a young woman who reports having multiple partners. Which statement by the patient indicates she understands the regimen?
d. "This type of pill has fewer side effects than other types."
Question 9: The primary care NP prescribes an inhaled corticosteroid for a patient who has asthma. The third-party payer for this patient denies coverage for the brand that comes in the specific strength the NP prescribes. The NP should:
d. write a letter of medical necessity to the insurer to explain the need for this particular medication.
Question 10: X primary care XX XXXXXXXXXX XXXXXXXXXXXXX for a patient to treat thyroid deficiency. When XXXXXXXX this XXXXXXX XXXXX the XXXXXXXXXX, the NP should:
d. tell XXX patient XXXX the drug XXX be XXXXXXX XXXX XXXXXXX XXXXXXXX tests XXXXXXXXX.
XXXXXXXX XX: X XXXXXXX who XXX had four XX XXXX XXXXXX XXXXXX per XXX XXX X XXXX XX seen XX the XXXXXXX XXXX NP. XXX patient XXXX about medications to stop the XXXXXXXX. XXX NP tells XXX patient that antidiarrheal XXXXXXXXXXX are:
d. XXXXXX when other XXXXXXXX, such XX hematochezia, develop.
Question XX: The XXXXXXX XXXX NP XXXX a patient XXXXXXX XX Medicaid, XXXXXX a prescription XXX a medication, and is informed by the pharmacist XXXX XXX XXXXXXXXXX XX “off-formulary.” The XX XXXXXX:
d. XXXXXXX the XXXXXXXXXXXXXX XXXXXXX to see XX medication samples XXX available.
Question XX: A XXXXXXX who has XXXX X diabetes mellitus XXXXX metformin (XXXXXXXXXX). XXX patient tells the XXXXXXX XXXX XX XXXX he will have XXXXXXX in a few XXXXX. XXX XX XXXXXX XXXXXXXXX:
d. adding a sulfonylurea XXXXXXXXXX XXXXX recovery from surgery XX complete.
XXXXXXXX XX: A XXXX 52-year-old woman XXX XXX XXXXXXXX XXX a hysterectomy tells XXX primary XXXX XX XXX XX XXXXXX frequent hot XXXXXXX and XXXXXXX dryness. X recent XXXX XXXXXXX XXXXX XXXXX early osteopenia. XXX XXXXX’s mother had CHD. XXX has no family history of breast XXXXXX. The NP XXXXXX XXXXXXXXX:
d. XXXXXXXX-XXXXXXXXXXXX XX in X XXXXX.
Question XX: A patient who XXX XXXXXXXX gastroparesis sees a gastroenterology XXXXXXXXXX who orders XXXXXXXXXXXXXX (Reglan). XXXXXX XX XXXXX, the patient describes having extrapyramidal XXXXXXXX (XXX) to the primary care NP. The XX XXXX contact the XXXXXXXXXXXXXXXXXX XXX should XXXXXX to prescribe:
d. a TCA.
Question XX: XXX XXXXXXX XXXX XX is preparing XX XXXXXXXXX XXXXXXXXXX dinitrate XXXXXXXXX release (Dilatrate XX) XXX a patient who has chronic, stable angina. The XX should XXXXXXXXX XXXXXXX XXXXXX of:
d. 80 XX XXXXX XXXXX XXXXX at X:00 XX, X:00 PM, XXX X:XX XX.
Question XX: A patient who XXX hypothyroidism XXX been XXXXXX XXXXXXXXXXXXX XX mcg daily for 2 XXXXX. XXX patient XXXXXXX XXXXXXXXX XXXXXXX. XXX primary XXXX NP XXXXXX:
d. XXXXXXXX XXX patient XXXX this will XXXXXXX in several weeks.
Question 18: XXX primary care NP XXX referred a XXXXX who XXX XXXXXXXXXXX gastrointestinal XXXXXX disease to a XXXXXXXXXX XXX XXXXXXXXXXXXX for a XXXXXXXXXXXXXX XXX XXXXXXXXXXX tube XXXXXXXXX. The XXXXX’s weight is 80% of XXXX is recommended for age, and a XXXXXX XXXXXXX XXXXX revealed XXXXXXXXXXX XXXX XXX aspiration. The child’s XXXXXXX XX XXX XXXX the procedure. The XX should:
d. XXXXXXXXXX XXXX XXX child's XXXXXXX have a right XX XXXX XXXXXXX that XXXXXXXX those XX the medical team.
XXXXXXXX 19: X female XXXXXXX XXX is XXXXXXXXXXX XXXXX the XXXXXXX care XX XXXX XXX has been XXXXX bisacodyl (Dulcolax) XXXXX for XXXXXXX years. The NP should:
d. counsel the patient to XXXXXXXXXXX XXX XXXXXXXX and XXXXXXXX fluid and fiber XXXXXX.
XXXXXXXX XX: X XXXXXXX XXXXX a cardiac medication that has a XXXX XXXXXX XXXXXXXXXXX XXXXX. The XXXXXXX care NP XXXXXX that XXX particular brand XXX XXXXXXX is taking XX XX longer covered by XXX XXXXXXX’s XXXXXXX XXXX. The NP knows that the XXXXXXXXXXXXXXX of the drug XXXXXX from XXXXX to brand. The XX should:
d. XXX XXX XXXXXXXXXXXXXX company XXXX makes the drug for samples so XXXX the XXXXXXX XXXX XXX incur out-of-XXXXXX XXXXXXX.
XXXXXXXX 21: X patient is in XXX clinic for a follow-XX XXXXXXXXXXX XXXXX a myocardial infarction (XX). The patient XXX a history of left ventricular systolic XXXXXXXXXXX. The primary XXXX NP XXXXXX XXXXXX XXXX patient to be XXXXXX:
a. XXXXXXX (Corgard).
b. carvedilol (XXXXX).
c. XXXXXXX (XXXXXXXXX).
d. propranolol (Inderal).
Question 22: X male XXXXXXX tells the primary XXXX NP he XX experiencing XXXXXXXXX XXXXXX, XXXX XX energy, XXX poor XXXXXXXXXXXXX. XXX XX performs an XXXXXXXXXXX XXX XXXXX increased body XXX XXX XXXXXXXXXXXX. X XXXXX XXXXXXXXXXXX level XX XXX ng/XX. XXX NP’s next action should be to:
d. XXXXXX a XXXXXXX XXXXX XXXXXXXXXXXX XXXXX.
Question 23: An African-XXXXXXXX XXXXXXX is XXXXXX XXXXXXXXX (XXXXXXX) 25 XX XXXXX daily. When performing a physical XXXXXXXXXXX, XXX primary care nurse XXXXXXXXXXXX (XX) learns XXXX the patient XXXXXXXXX to have XXXXX pressure XXXXXXXX of XXX/90 XX XX. The XX XXXXXX:
d. recommend a low-sodium XXXX in XXXXXXXX to XXX medication.
Question XX: A 50-year-XXX woman who is XXXXXXXXXXXXXX is taking an XXXXXXXXX XXXXXXXXX XX XXXX of a XXXXXX cancer treatment XXXXXXX. She XXXXX her primary XXXX NP to XXXXXX XXXX she XXX had XXX flashes XXX XXXXXXXXX XXXXXXX XXXXXXXXX but no XXXXXXXX. XXX XX XXXXXX:
d. reassure her that these are normal side effects of XXX XXXXXXXXXX.
Question 25: X 40-year-old XXXXXXX is in XXX clinic XXX a routine XXXXXXXX XXXXXXXXXXX. The patient has a body mass XXXXX (XXX) XX XX. The patient is active XXX walks a dog XXXXX. A lipid profile XXXXXXX XXX-density lipoprotein (XXX) XX XXX mg/XX, XXXX-XXXXXXX lipoprotein (HDL) of XX XX/XX, and XXXXXXXXXXXXX of XXX mg/dL. The XXXXXXX care nurse XXXXXXXXXXXX (XX) should:
d. obtain serum XXXXXXX and XXXXXXXXXX A1c XXXXXX.
Question 26: XXX primary XXXX XX XX XXXXXX a patient XXX a XXXXXXXX follow-XX after XXX XXXXXXX XXX had a XXXXX myocardial XXXXXXXXXX. XXX patient XXX a XXXX XX the XXXXXXXXXX medications and tells the XX XXXX “XX XXX XXXXXXXXX XXXXXXXX XXXXX XXXX.” XXX XX’s initial response XXXXXX XX to:
d. XXXX the XXXXXXX information about drug effects and XXX adverse reactions.
XXXXXXXX XX: X man with a BMI of 38 XXX a waist size of 48 XXXXXX is seen in the clinic XXX an annual XXXX check-XX. XXX primary care XX orders laboratory XXXXX and XXXXX a fasting XXXXXX XXXXXXX XX XXX mg/dL, triglyceride XXXXX of 220 mg/dL, and high-density XXXXXXXXXXX level of XX mg/dL. XXX man’s blood pressure XX XXX/110 mm Hg. XXX man XXX a XXXXXXX XX cardiovascular XXXXXXX XXX tells the NP he has XXXXX to XXXX XXXXXX XXXXXXXX XXXXX. The XX XXXXXX XXXXXXXX:
d. a XXXXXX XXX-fat, XXX-sodium XXXX.
Question 28: A primary care XX XXXXXX XXXXXXX XXXXXXXX tests. The XXXXXXX’s XXX XX X.2 XXXXXXXXXX/mL, and XX is X.7 ng/XX. XXX XX XXXXXX:
d. ask an endocrinologist to XXXXXXXX for possible XXXXXXXXX's thyroiditis.
XXXXXXXX 29: A postmenopausal XXXXX develops XXXXX-induced XXXXX. XXX XXXXXXX care XX should prescribe:
d. pantoprazole (XXXXXXXX).
Question XX: A patient XXX XX newly diagnosed XXXX type X XXXXXXXX mellitus has XXX XXXXXXXXX to changes in XXXX or XXXXXXXX. The XXXXXXX is mildly obese and has a XXXXXXX XXXXX XXXXXXX of 130 XX/XX. The XXXXXXX XXX XXXXXX renal XXXXXXXX tests. The primary care XX XXXXX to XXXXXXXXX a XXXXXXXXXXX XXXXXXX. Which XX the XXXXXXXXX is XXXXXXXXX for this XXXXXXX?
d. XXXXXXXXX/XXXXXXXXXXXX (XXXXXXXX XXX)
Question XX: A XXXXXXX comes to XXX XXXXXX XX discuss weight loss. XXX primary care NP XXXXX a XXX XX 32 and XXXXXXXX a health risk assessment that XXXXXXX no obesity-XXXXXXX XXXX factors. XXX XX XXXXXX XXXXXXXXX:
d. Metformin/XXXXXXXXXXXX (ACTOplus met)
Question XX: X XXXXXXX XXX been using an herbal supplement XXX 2 years XXXX the XXXXXXX care NP knows may have toxic side effects. XXX NP XXXXXX:
d. prescribe another herbal drug that has fewer XXXXXXX XXXXXXX than XXX one XXX patient XX XXXXXX.
Question XX: X patient XXX has insulin-dependent XXXX X XXXXXXXX reports XXXXXX difficulty XXXXXXX XXXXX XXXXXXX XXXXXX XXXXXX XXXXXX XXX XXX had multiple XXXXXXXX of both hypoglycemia XXX XXXXXXXXXXXXX. XX adjunct therapy XX XXXXXX XXXX XXXXXXX, XXX XXXXXXX care NP should XXXXXXXXX:
d. XXXXXXXXX (XXXXXXXXXX).
Question 34: X XXXXXXX XXX XXXXX spironolactone for XXXXX failure has XXXXX taking digoxin (XXXXXXX) for atrial fibrillation. XXX XXXXXXX care NP provides teaching XXX XXXX patient XXX asks XXX patient to XXXXXX XXXX XXXX XXX XXXX XXXXXXX. Which statement by XXX XXXXXXX XXXXXXXXX XXXXXXXXXXXXX of XXX teaching?
d. "I should XXX a salt XXXXXXXXXX while XXXXXX XXXXX XXXXXXXXXXX."
XXXXXXXX XX: X XXXXXXX who XX XXXXXX nifedipine develops XXXX XXXXX XX both XXXX. XXX primary care XX XXXXXX contact the patient’s cardiologist to XXXXXXX:
d. XXXXXXXXXX of XXXX XXXXXXXXXXX XXXXXXXX.
Question XX: X patient who XXX atrial XXXXXXXXXXXX (XX) has XXXX XXXXXX warfarin (XXXXXXXX). The XXXXXXX care nurse XXXXXXXXXXXX (NP) plans to XXXXXX XXX XXXXXXX’s medication XX dabigatran (XXXXXXX). To do XXXX safely, the XX should:
d. order XXXXXXXX XXXXXXXXXX of XXX patient's INR XXXXX dabigatran therapy begins.
Question 37: X XXXXXXX who takes an XXX XXXXXXXXX and a thiazide diuretic for XXXXXXXXXXXX XXXX XXXXX XXXXXX spironolactone. XXX XXXXXXX XXXX NP XXXXXX XXXXXXX this patient to:
d. XXXXX XXXXXX antacids containing XXXXXXXXX while XXXXXX XXXXX drugs.
XXXXXXXX XX: A XXXXXXX XXX XXXX XXXXXX furosemide XX XX XXXX daily for 4 XXXXX and XXXXXXX XXX a follow-XX visit. The primary XXXX NP XXXXX a XXXXX XXXXXXXX of 100/XX mm Hg. The XXXXXXX’s lungs XXX clear, and there is XX peripheral edema. The patient’s XXXXX potassium XX 3.X XXX/L. The NP should:
d. XXXXXX XXXXXXXXXX dose the 40 XX XXXXX XXXXX.
Question XX: The primary care NP XX XXXXXXXXX XXXXXXXX-based recommendations about XXX off-XXXXX XXX XX a particular XXXX. Which recommendation XXXXXX XXXXXXXXX the XX’s XXXXXXXX about prescribing the XXXXXXXXXX?
d. Endorsement XX XXXX use by a XXXXXXX XXXXXXXXXXXX in XXX field
Question 40: A XXXXXXX who has a XXXXXXX of chronic XXXXXXXXXXXX uses a bulk laxative to prevent XXXXXXXX XX XXXXX constipation. The XXXXXXX reports having an XXXXXXXXX frequency XX episodes. The XXXXXXX XXXX XX should recommend:
d. adding XXXXXXXXXXXXXXXX measures XXXX XX XXXXXXXXXXX.
XXXXXXXX 41: A primary care XX XXXX a 5-XXXX-old child who is morbidly XXXXX. XXX child XXX an elevated XXXXXXXXXX A1c XXX increased lipid levels. Both of the XXXXX’s parents are overweight but XXX obese, and XXXX tell the XX XXXX they see nothing XXXXX with their XXXXX. XXXX both XXXXX XXXX it XX XXXXXXXXX to refuse their XXXXX’s XXXXXXXX XXX soda or XXX XXXXX. XXX NP XXXXXX:
d. XXXXXXX XXXXXX counseling XX explore XXXX XX improve parenting XXXXXX XXX XXXXXX.
Question XX: A 55-XXXX-XXX patient XXXX no prior history XX hypertension XXX a blood pressure XXXXXXX XXXX XXX/90 XX XXXXX XXXXXXXX occasions. XXX patient does not XXXXX, has a body mass index XX 24, and exercises XXXXXXXXX. The XXXXXXX has XX known risk XXXXXXX for XXXXXXXXXXXXXX disease. The primary XXXX NP should:
d. order a urinalysis and creatinine XXXXXXXXX and XXXXX therapy with a b-XXXXXXX.
Question XX: A patient who has XXXXXXXX mellitus XXX XXXXXXXXXX XXXXX XXXXXXX XXXXX XXXXXXX and XXXXXXXX. The patient XXXX begin taking exogenous testosterone XX treat XXXXXXXXX hypogonadism. XXX primary XXXX NP should recommend:
d. XXXXXXXXXX XXXXXXX doses to XXXXXXX XXXXXXXXXXXX.
Question XX: X primary care NP sees a XXXXXXX XXX XXXXXXX XXXXXX decreased frequency XX XXXXXX over the past XXX XXXXXX. XX XXX XXXXXX XXXXX, XXX patient has XXXXXX XXXXXXXXX XXXXXXXX and an abdominal XXXXXXXXXX shows an increased XXXXX load in XXX sigmoid XXXXX and rectum. XXX NP XXXXXX:
d. recommend polyethylene glycol (XXXXXXX) and 2000 XX of XXXXX XXXXX.
Question 45: A primary care XX writes a XXXXXXXXXXXX XXX an XXX-XXXXX use for a drug. To help XXXXXX compliance, XXX NP should:
d. XXXXXX up by XXXXX in several days to XXX if XXX patient is XXXXX XXX drug XXXXXXXXXXXXX.
Question 46: A patient wants XX XXXX why a cheaper version of a drug XXXXXX XX used when the XXXXXXX care NP XXXXXX a prescription for a XXXXXXXX XXXXX name of the XXXX and XXXXXX, “Dispense as XXXXXXX.” XXX NP should XXXXXXX that a different XXXXX of XXXX drug:
d. XXX vary in the amount of drug that XXXXXXX XXX XXXX XX XXXXXX in the body.
Question XX: A 2-XXXX-old XXXXX has XXXXXXX “toddler’s” diarrhea, which XXX an unknown XXX benign XXXXXXXX. The child’s XXXXXX XXXX XXX XXXXXXX XXXX NP if a medication can be XXXX to treat the child’s XXXXXXXX. XXX XX should XXXXXXXXX XXXXXX:
d. XXXXXXX subsalicylate (XXXXX-XXXXXX).
Question XX: X XXXXXXX XXXX NP has prescribed XXXXXXXXXXX XXX a XXXXXXX XXX XX XXXXX. The patient XXXXX XX lb in the XXXXX month but reports XXXX the drug XXXX XXX seem XX XX suppressing XXXXXXXX XX much as before. The NP should:
d. change XX a XXXXXXXXXXX XX XXXXXXXXXXX and XXXXXXXXXX.
Question 49: X XXXXXXX XX newly diagnosed with type 2 diabetes mellitus. XXX XXXXXXX care NP XXXXXXX XXXX XXXXXXX’s XXXXXXXXXX XXXXX and XXXXX normal renal XXXXXXXX, XXXXXXXXX XXXXXXXXXXXXX, and XXXXXXXX HDL XXXXXX. The XX should prescribe:
d. XXXXXXXXX (Glucophage).
XXXXXXXX: A 50-year-XXX woman XXXX a family history of XXX is XXXXXXXXXXXX occasional hot flashes XXX XX having XXXXXXX every X to X months. XXX XXXX the XXXXXXX XXXX XX about HT to relieve her XXXXXXXX. XXX NP XXXXXX:
d. plan XX XXX estrogen-XXXXXXXXXXXX therapy when XXXXXXXXX XXXXXX.
XXXXXXXX 51: A primary care NP prescribes a XXXX for a woman XXX XX taking XXXX for the XXXXX time. XXXXX teaching, XXX XXXXX XXXXXX correctly state XXX XXXX for using a backup form of contraception XX XXX:
d. XXX XXXXXXXXX headaches or XXXXXXXX.
XXXXXXXX 52: X XXXXXXX who XX taking an XXXX XXXXXXXXXXXXX XX in the XXXXXX in XXX XXXX XXXXXXXXX and reports having missed XXX morning dose XX XXX XXXXXXXXXX because XXX XXXXXXXXXXXX XXX XXX XXXXXXXX. The XXXXXXX XXXX NP should XXXXXXX this XXXXXXX XX:
d. XXXX today's XXXX XXX XXXXXX a regular dosing XXXXXXXX in the XXXXXXX.
XXXXXXXX XX: A XXXXXXX comes XX the clinic XXXX a X-day XXXXXXX of cough XXX wheezing. The patient has no XXXXXXXX XXXXXXX XX XXXXXX. The XXXXXXX XXXXXXX having heartburn for XXXXXXX XXXXXX, which has worsened considerably. XXX XXXXXXX care XX makes a diagnosis of asthma and XXXXXX oral XXXXXXXX and inhaled albuterol. The XXXXXXX’s XXXXXXXXX XXXXXXX, and a XXXXX radiograph obtained X XXXX XXXXX XXXXX bilateral XXXXXXXXXXX. The NP has failed XX:
d. XXXXX the drugs an adequate XXXXXX XX time XX XXXX.
XXXXXXXX 54: A X-XXXX-old XXXXX has chronic XXXXXXXXXXXX. The XXXXXXX XXXX NP XXXXX XX prescribe a XXXXXXXX XXX long-term management. In XXXXXXXX XX pharmacologic XXXXXXX, XXX NP should XXXX recommend _____ g of fiber per day.
d. XX
Question 55: X patient in XXX clinic XXXXXXX XXXXXXXXX XX XXXXXXX XXXXX XXXXX, a feeling XX fullness, XXXXXXXX belching, and a XXXXXXXX sour taste. The XXXXXXX has a normal weight XXX XXXXXXX XXXXXX a XXXX-stress job. XXX XXXXXXX care XX XXXXXX recommend:
d. consultation XXXX a XXXXXXXXXXXXXXXXXX XXX endoscopy.
XXXXXXXX 56: A XXXXXXX XXX XXX XXXXXX is XXXXXX nitroglycerin XXX XXXX-XXXXXX nifedipine. XXX primary care NP notes a persistent blood pressure XX XX/60 mm Hg at several XXXXXX-up XXXXXX. The patient reports XXXXXXXXXXXXXXX XXXXXXXXXX with XXXXXXXX XX. The NP XXXXXX consult with the patient’s cardiologist XXXXX XXXXXXXX XXX medication XX:
d. XXXXX-acting nifedipine (Procardia).
XXXXXXXX 57: A XX-year-old woman tells XXX XXXXXXX XXXX XXXXX practitioner (XX) that XXX does not XXXX XXXX children XXX XXXXX XXXX a XXXXXXXXXXXXX. She XXXX XXX XXXXX XXX XXX XX personal or XXXXXX XXXXXXX XX cardiovascular disease. XXX has frequent XXXXXXX headaches. XXX XXXX XXXXXXX, XXX NP should XXXXXXXXX:
d. XXX-estrogen COCP.
Question XX: A XXXXX XXX XXX XXXX XXXXXX a XXXX XXXXX XXX XXXXXXX care XX that, because XX XXXXXXXX XXXXXXX in her XXXX schedule, she has difficulty XXXXXXXXXXX to XXXX her XXXXX. The XXXXX and XXX XX decide to change XX a XXXXXXX ring. XXX NP will XXXXXXXX her to insert the XXXX:
d. XX the same day she stops taking her COCP.
XXXXXXXX XX: X XXXXXXX who has XXXXXX arthritis XXX who takes XXXXXXXXXXXX antiinflammatory XXXXX (NSAIDs) XXXXX XXXXXXXX a XXXXXXXX XXXXX. The patient XXX XXXXX a cyclooxygenase-2 XXXXXXXXX XXXXX in the XXXX XXX XXXXXX XXXX it is XXX XX effective XX XXX XXXXXXX NSAID. XXX XXXXXXX XXXX XXXXX practitioner (XX) XXXXXX:
d. change the NSAID XX a corticosteroid.
Question 60: A XXXXXXX in XXX XXXXXX XXXXXXXX XXXXXX XXXXXXXXX XX XXXXXX and XXXXXXXXXXX. XXX XXXXXXX care NP XXXXX thready XXXXXX, XXXX peripheral XXXXXXXXX, and a decreased level XX XXXXXXXXXXXXX. The NP XXXXXXXXX the XXXXXXXXX medical XXXXXX and XXXXXX anticipate that this XXXXXXX XXXX XXXXXXX:
d. unfractionated XXXXXXX (UFH) XXX warfarin.
XXXXXX
X. add XXXXXXXXX (Zetia) and XXXXX the atorvastatin XX 10 mg XXXXX.
2. order a XXXXXXXX XXXXXX-XX (CK-MM) XXXXX.
3. XXXXX XXXXXXXXXXX therapy.
X. XXXXXXXX-only XX.
5. XXXXX one XXXXX daily in the morning XXX remove in 12 XXXXX.
6. XXX XXX XXXXXX to identify XXX XX XXX XXXXXXXXXXX listed on the XXXXXXXXXX label.
X. XXXXXXXXXX (XXXXXX)
8. "I should XXXXXX to XXXX XXXX four periods XXXX year."
X. order the XXXXXXX formulary-approved XXXXXXXXXXXXX of the drug XXX monitor XXXXXXXXXXXXX.
XX. XXXX the patient XXXX XXXXXXXX XXXXXX of XXX medication should be avoided.
XX. XXX XXXXXXXX and XXX prolong XXX illness.
12. XXXXX XXX prescription XXX a XXXXXXX XXXX XX it XXXXX the patient's needs.
13. using XXXXXXX XXXXXX the perioperative XXX postoperative XXXXXXX.
14. XXXXXXXX-XXXX HT XXX.
XX. benztropine (XXXXXXXX).
XX. 40 XX XXXXX daily XX minutes XXXXXX XXXXX.
XX. XXXXX the TSH XXXXX in 1 XXXX.
18. XXXXXXXX a XXXXXXXXXX with XXX parents about XXX potential outcomes of XXXX possible action.
XX. XXXXXXXXX docusate sodium (Colace) and decrease bisacodyl gradually.
XX. XXXXXXX XXX XXXXXXXXX XXXXXXXX XX XXXXXXX XXX XXXX particular XXXXXXXXXXX is XXXXXXXXX.
XX. carvedilol (XXXXX).
22. XXXXXX a XXXXXXX serum testosterone level.
XX. add a thiazide XXXXXXXX XX this XXXXXXX's regimen.
XX. schedule her XXX a gynecologic XXXXXXXXXXX.
25. order a fasting plasma glucose level.
26. determine what XXX patient understands about XXXXXXXX artery XXXXXXX.
27. XXXXXXXX (Xenical).
XX. XXXX the XXXXXXX XXXX the XXXXXXX most likely XXXXXXXX XXXXXXXXXXXXXX.
29. ranitidine (Zantac).
30. XXXXXXXXX/glyburide (XXXXXXXXXX)
XX. XXXXXXXXX/XXXXXXXXX (Glucovance)
32. inform the XXXXXXX of XXX risks of toxic XXXX XXXXXXX XXXX XXXX supplement.
33. XXXXXXXXXXX (XXXXXX).
XX. "I should avoid high-sodium foods."
XX. XXXXXXXX to amlodipine.
36. XXXXXXXX dabigatran when XXX XXXXXXX's international normalized XXXXX (INR) is XXXX than X.
XX. avoid foods that XXX high in potassium.
XX. decrease furosemide XX XX mg XXXX XXXXX.
XX. Data from XXXXXXXXXX, XXXXXXXXXXXX studies
XX. adding XXXXXXXX sodium (Colace).
41. XXXXXXXX a XXXXXXXX with XXX XXXXXXX XXXXX the implications XX the XXXXX's XXXXXXXXXX values.
42. XXXXXXX a careful cardiovascular physical XXXXXXXXXX.
XX. XXXX XXXXXXXX blood glucose XXXXXXXXXX.
XX. order a sodium phosphate XXXXX and XXXXXXXX (XXXXXXXXX).
45. include information about the XXX-XXXXX XXX XX XXX E-XXXXXX.
46. XXX vary in the XXXXXX XX XXXX that XXXXXXX XXX XXXX of action in XXX body.
47. an XXXXXXXXXXX solution (XXXXXXXXX).
48. XXXXXXXXXXX XXX phentermine.
49. XXXXXXXXX (XXXXXXXXXX).
XX. plan to use estrogen-XXXXXXXXXXXX XXXXXXX XXXX menopause XXXXXX.
XX. is having vomiting or XXXXXXXX.
52. XXXX XXXXX's XXXX XXX resume a regular XXXXXX schedule in XXX morning.
XX. XXXXXXX XXX diagnosis.
XX. 10
55. daily XXXXXXXXX XXXX a XXX.
56. XXXXXXXXX HCl (XXXXX).
57. low-XXXXXXXX XXXX.
58. XXXXXX 7 days XXXXX her XXXX active pill.
XX. prescribe omeprazole (XXXXXXXX).
XX. XXXXXXXXXXXXXX heparin (UFH) and warfarin.
">